Ardelyx (ARDX) Stock: Buy, Sell, or Hold?
ARDX - Ardelyx, Inc.
$3.08
-0.12 (-3.75%)
▼
5d:
-0.32%
30d:
-10.72%
90d:
-39.13%
HOLD
MODERATE Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 03, 2026
9d
Get Alerted When ARDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ARDX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ARDX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.00
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.35
29.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ARDX is currently trading at $3.08, which is considered oversold relative to its 30-day fair value range of $3.18 to $3.46. From a valuation perspective, the stock is trading at a discount (Forward PE: 10.6) compared to its historical average (17.2). Remarkably, the market is currently pricing in an annual earnings decline of 15.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ARDX is in a strong downtrend. The price is currently testing key support at $3.02. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: ARDX scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.80 (+315.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ARDX is in a strong downtrend. The price is currently testing key support at $3.02. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: ARDX scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.80 (+315.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.18 -
$3.46
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
Protect Your Profits
Holding ARDX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (32/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.8%)
- BULLISH: Trading 315.6% below Wall St target ($12.80)
Trading Range Analysis
30-Day Trading Range
$3.18 -
$3.46
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.02
Resistance Level
$3.35
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.60
Wall Street Target
$12.80
(+315.6%)
Revenue Growth (YoY)
23.8%
Profit Margin
-12.3%
Valuation Discount vs History
-15.0% cheaper
PE vs Historical
10.6 vs 17.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-15.0%
(market-implied from PE analysis)
1-Year Target
$2.77
(-10%)
2-Year Target
$2.49
(-19%)
3-Year Target
$2.25
(-27%)
3-Yr Target (if PE normalizes)
(PE: 11→17)
$3.64
(+18%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.6 to 17.2
Stabilization Target:
$5.00
(+62.2%)
PE Expansion Potential:
+62.2%
Share & Embed Analysis
Last updated: October 23, 2026 9:13 PM ET
Data refreshes hourly during market hours. Next update: 10:13 PM
Data refreshes hourly during market hours. Next update: 10:13 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$258 | 61 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$72 | 48 HOLD |
Advanced ARDX Option Strategies
Professional options setups generated by AI based on today's ARDX price and gamma walls.
